The Global Kinase Inhibitors market is expected to reach USD 95.3 Billion by 2030, at a CAGR of 7.3% during the forecast period 2022 to 2030.The Global Kinase Inhibitors Market is expanding due to an increase in the incidence of cancer and other chronic diseases, a rise in cancer diagnosis awareness, and an increase in clinical trials for cancer therapy.